Novo Nordisk is continuing to lose ground in the obesity and diabetes markets, with the Danish drugmaker saying it expected ...

Novo launched a rival bid to acquire American obesity biotech firm Metsera last week, superseding an offer for the firm from ...

As Ozempic use rises, society’s obsession with thinness is erasing body positivity and real, authentic bodies.

Scientists from Laval University and the University of Texas Southwestern Medical Center have joined forces to understand ...

The lowest doses of Eli Lilly’s Zepbound and Novo Nordisk's Wegovy could be available for as little as $149 a month.

Walmart is joining Costco, Sam’s Club, and CVS in offering cheaper prices for customers paying out of pocket for Zepbound, ...

Novo Nordisk, as well as Eli Lilly, would gain Medicare and Medicaid coverage for their blockbuster weight-loss drugs.

Obesity drugs have become an increasingly popular method of weight loss but most are not covered by insurance for that ...

People looking to lose weight and lower their blood sugar may someday be able to get a single injection that turns their ...

New research shows that a new weight-loss drug called MariTide might offer a powerful alternative to current weekly ...